Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35,600
Closed -$408K 1090
2023
Q2
$408K Sell
35,600
-12,100
-25% -$132K ﹤0.01% 966
2023
Q1
$527K Sell
47,700
-7,200
-13% -$74.5K ﹤0.01% 954
2022
Q4
$486K Hold
54,900
﹤0.01% 993
2022
Q3
$463K Sell
54,900
-2,700
-5% -$25.7K ﹤0.01% 976
2022
Q2
$567K Hold
57,600
﹤0.01% 953
2022
Q1
$666K Sell
57,600
-11,700
-17% -$123K ﹤0.01% 1004
2021
Q4
$710K Sell
69,300
-30,100
-30% -$329K ﹤0.01% 987
2021
Q3
$1.16M Buy
+99,400
New +$1.36M ﹤0.01% 949
2020
Q4
Sell
-25,700
Closed -$264K 1283
2020
Q3
$264K Buy
+25,700
New +$313K ﹤0.01% 1122

Other funds holding ECVT

Axa's ECVT Position: Q3 2023 in Review

Axa sold out of Ecovyst (ECVT) in Q3 2023, closing a stake of 35,600 shares — an estimated $408K sold.

Axa first reported a position in ECVT in Q3 2020 and held it in 9 quarters. The position peaked at $1.16M in Q3 2021. 152 funds tracked by Wall St. Rank hold ECVT as of Q3 2023.

  • Axa reported no remaining Ecovyst position as of Q3 2023 after selling out during the quarter.
  • Axa sold 35,600 Ecovyst shares in Q3 2023, an estimated $408K.
  • Axa first reported a position in Ecovyst in Q3 2020 and held it in 9 quarters.
  • Axa's Ecovyst position peaked at $1.16M in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Ecovyst as of Q3 2023.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.